Park Chan Hyuk, Kim Eun Hye, Kang Jung Hyun, Chung Hyunsoo, Park Jun Chul, Shin Sung Kwan, Lee Sang Kil, Lee Yong Chan
Department of Internal Medicine, Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
PLoS One. 2016 Jan 25;11(1):e0147874. doi: 10.1371/journal.pone.0147874. eCollection 2016.
Gastric cancer with undifferentiated histology has different clinicopathologic characteristics compared to differentiated type gastric cancer. We aimed to compare the risk of synchronous or metachronous tumors after curative resection of early gastric cancer (EGC) via endoscopic submucosal dissection (ESD), according to the histologic differentiation of the primary lesion.
Clinicopathological data of patients with initial-onset EGC curatively resected via ESD between January 2007 and November 2014 in a single institution were reviewed. We analyzed the incidence of synchronous or metachronous tumors after ESD with special reference to the differentiation status of the primary lesion.
Of 1,560 patients with EGC who underwent curative resection via ESD, 1,447 had differentiated type cancers, and 113 had undifferentiated type cancers. The cumulative incidence of metachronous or synchronous tumor after ESD was higher in the differentiated cancer group than in the undifferentiated cancer group (P = 0.008). Incidence of metachronous or synchronous tumor was 4.8% and 1.2% per person-year in the differentiated and undifferentiated cancer groups, respectively. The Cox proportional hazard model revealed that undifferentiated cancers were associated with a low risk of synchronous or metachronous tumors after adjusting for confounding variables (hazard ratio [95% confidence interval] = 0.287 [0.090-0.918]).
The rate of synchronous or metachronous tumors after curative ESD was significantly lower for undifferentiated cancers compare to differentiated cancers. These findings suggest that ESD should be actively considered as a possible treatment for undifferentiated type EGCs.
与分化型胃癌相比,未分化组织学类型的胃癌具有不同的临床病理特征。我们旨在根据原发性病变的组织学分化情况,比较早期胃癌(EGC)经内镜黏膜下剥离术(ESD)根治性切除术后发生同步或异时性肿瘤的风险。
回顾了2007年1月至2014年11月在单一机构经ESD根治性切除的初发性EGC患者的临床病理资料。我们特别参考原发性病变的分化状态,分析了ESD术后同步或异时性肿瘤的发生率。
在1560例行ESD根治性切除的EGC患者中,1447例为分化型癌,113例为未分化型癌。ESD术后异时性或同步性肿瘤的累积发生率在分化型癌组高于未分化型癌组(P = 0.008)。分化型和未分化型癌组中,异时性或同步性肿瘤的发生率分别为每人年4.8%和1.2%。Cox比例风险模型显示,在调整混杂变量后,未分化癌与同步或异时性肿瘤的低风险相关(风险比[95%置信区间]= 0.287 [0.090 - 0.918])。
与分化型癌相比,未分化癌根治性ESD术后同步或异时性肿瘤的发生率显著更低。这些发现表明,ESD应被积极视为未分化型EGC的一种可能治疗方法。